Company Filing History:
Years Active: 2021-2022
Title: Jillian M Prendergast: Innovator in Glycan-Interacting Compounds
Introduction
Jillian M Prendergast is a notable inventor based in Maynard, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of glycan-interacting compounds. With a total of 2 patents, her work focuses on innovative methods for treating cancer.
Latest Patents
Jillian's latest patents include groundbreaking inventions related to glycan-interacting antibodies. The first patent, titled "Glycan-interacting compounds and methods of use," outlines methods for treating cancer by administering glycan-interacting antibodies. This includes anti-sialyl Tn antigen antibodies and related compositions designed to achieve desirable bioactivity, bioavailability, and toxicity levels. The second patent also titled "Glycan-interacting compounds and methods of use," provides methods for producing glycan-interacting antibodies that are useful in the treatment and prevention of human diseases, including cancer. This patent encompasses humanized antibodies, derivatives, and fragments, along with related compositions and kits for treatment and diagnosis.
Career Highlights
Jillian is currently employed at Seagen Inc., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the biotechnology sector, particularly in cancer treatment innovations.
Collaborations
Jillian collaborates with esteemed colleagues such as David A Eavarone and Daniel T Dransfield, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jillian M Prendergast is a pioneering inventor whose work in glycan-interacting compounds is making a significant impact in the field of cancer treatment. Her patents reflect her commitment to advancing medical science and improving patient outcomes.